Concepedia

Marco Thomann

MT

Statistics

Publications

11

Citations

700

H-Index

11

Active since

2014

Affiliations

Roche Pharma AG (Germany)(Current)

CS Diagnostics

Roche (Switzerland)

Leiden University Medical Center

Technical University of Munich

Marco Thomann is an author at Roche Pharma AG (Germany) specializing in biochemistry, glycobiology, and protein glycosylation.

Publications per year

2014–2024

11

Publications

11

In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

Marco Thomann, Tilman Schlothauer, Tetyana Dashivets et al. · PLoS ONE · 2015 · 217 citations · Full text

, , +17

Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies

Marco Thomann, Katharina Reckermann, Dietmar Reusch et al. · Molecular Immunology · 2016 · 183 citations · Full text

, , +17

Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants

Tetyana Dashivets, Marco Thomann, Petra Rueger et al. · PLoS ONE · 2015 · 101 citations · Full text

, , +17

Assessing production variability in empty and filled adeno-associated viruses by single molecule mass analyses

Eduard H.T.M. Ebberink, Alisa Ruisinger, Markus Nuebel et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 58 citations · Full text

, , +15

Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody

David Falck, Marco Thomann, Martin Lechmann et al. · mAbs · 2020 · 42 citations · Full text

, , +17

1–5 of 11